Olon Group is a global leader in the development and production of active pharmaceutical ingredients for CDMO and Generics, a reliable and preferential partner to the pharmaceutical, biotech, and specialty ingredients markets. With a 2021's turnover of 580 Mio$, OLON supplies 300 APIs for the Generic market.

Thanks read moreto all the 2.300 employees, and to highly qualified R&D team – more than 300 people – OLON can offer complete integrated packages and services to support the full development of APIs based on strong knowledge in both Chemical and Biological process, all of them under a full cGMP and regulatory coverage – holder of about 160 active US DMFs and 79 granted CoS.

Headquartered in Rodano (Milan, Italy), OLON has 11 manufacturing facilities - 8 located in Italy, 1 in Spain, 1 in USA and 1 in India, designed in compliance with the strictest international requirements, and 3 branch offices in Hamburg (Germany), Florham Park, NJ (USA) and Shanghai (China). [website]

Onyx Scientific offers Custom Synthesis and Manufacturing services from Med-Chem to Commercial Programs. We offer customers “BEST OF BOTH WORLDS” in executing early phase programs from our UK sites and late phase programs from FDA/MHRA approved India locations. Onyx Scientific offers FTE services, Process R&read moreamp;D, Solid State characterisation, Scale-up and manufacturing services. Chemistry capabilities include chiral synthesis, steroids and hormones development, biotinylation & heterocyclic compounds. [website]